| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 219,746 | 172,458 | | Cost of Revenue | 59,142 | 57,254 | | | Gross Profit | 160,604 | 115,204 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 92,154 | 90,628 | | Non Recurring | (4,073) |
-
| | Others | 32,339 | 14,066 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 40,184 | 10,510 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | 40,184 | 10,510 | | Interest Expense | 19,773 | 16,520 | | Income Before Tax | 20,411 | (6,010) | | Income Tax Expense | 3,865 | (4,465) | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 16,546 | (1,545) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 16,546 | (1,545) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $16,546 | ($1,545) |
|
0.22% Nasdaq 
Income Statement
